|
ACPL2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.66133814775094E-16 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.80089276824447E-12 |
| Normal-vs-Stage2 |
1.041470E-04 |
| Normal-vs-Stage3 |
4.412200E-04 |
| Normal-vs-Stage4 |
1.460470E-02 |
| Stage1-vs-Stage2 |
4.841000E-01 |
| Stage1-vs-Stage3 |
2.584200E-01 |
| Stage1-vs-Stage4 |
9.902200E-02 |
| Stage2-vs-Stage3 |
1.959800E-01 |
| Stage2-vs-Stage4 |
6.378000E-02 |
| Stage3-vs-Stage4 |
4.777400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.91819901576673E-11 |
| Normal-vs-AfricanAmerican |
3.103800E-03 |
| Normal-vs-Asian |
8.007200E-04 |
| Caucasian-vs-AfricanAmerican |
7.205200E-01 |
| Caucasian-vs-Asian |
6.783200E-01 |
| AfricanAmerican-vs-Asian |
9.693400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.64290000048695E-07 |
| Normal-vs-Female |
4.03677091753707E-13 |
| Male-vs-Female |
4.831200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.43970002375715E-09 |
| Normal-vs-Age(41-60Yrs) |
1.20900000011304E-08 |
| Normal-vs-Age(61-80Yrs) |
3.08120000003242E-06 |
| Normal-vs-Age(81-100Yrs) |
1.864560E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.543800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.975200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.315800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.348400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.276400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.745800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.08300052154209E-11 |
| Classical-VS-Follicular |
1.340320E-02 |
| Classical-VS-Other |
4.010400E-01 |
| Classical-VS-Normal |
3.3708591473669E-12 |
| Tall-VS-Follicular |
3.90800003469138E-09 |
| Tall-VS-Other |
3.336100E-02 |
| Tall-VS-Normal |
7.650800E-01 |
| Follicular-VS-Other |
8.935400E-01 |
| Follicular-VS-Normal |
4.69740002451147E-09 |
| Other-VS-Normal |
3.608400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.04236627610044E-12 |
| Normal-vs-N1 |
9.642100E-03 |
| N0-vs-N1 |
4.682000E-03 |
|
|
